Columbia University Medical Center, Edward Harkness Eye Institute
New York, New York, United States
Eye care center in New York City, New York
635 W 165th St, New York, NY 10032
About Columbia University Medical Center, Edward Harkness Eye Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
4D Molecular Therapeutics
1
Columbia University
1
Clinical Trials at Columbia University Medical Center, Edward Harkness Eye Institute
During the past decade, Columbia University Medical Center, Edward Harkness Eye Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
2020-06-09
2029-05-01
Active, not recruiting
21
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Columbia University Medical Center, Edward Harkness Eye Institute
According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center, Edward Harkness Eye Institute" are
"Age-related Macular Degeneration" (1 trials), "Central Serous Retinopathy" (1 trials), "Choroidal Ischemia" (1 trials), "Retinitis Pigmentosa" (1 trials) and "Vitelliform Macular Dystrophy" (1 trials). Many other conditions were trialed in "Columbia University Medical Center, Edward Harkness Eye Institute" in a lesser frequency.
Clinical Trials Intervention Types at Columbia University Medical Center, Edward Harkness Eye Institute
Most popular intervention types in "Columbia University Medical Center, Edward Harkness Eye Institute" are "Other" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "4D-125 IVT Injection" (1 trials), "Observational" (1 trials), "Ocular Coherence Tomography-Angiography (OCT-A)" (1 trials), "Sildenafil" (1 trials) and "Standard of Care Sildenafil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia University Medical Center, Edward Harkness Eye Institute
The vast majority of trials in "Columbia University Medical Center, Edward Harkness Eye Institute" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Columbia University Medical Center, Edward Harkness Eye Institute
Currently, there are NaN active trials in "Columbia University Medical Center, Edward Harkness Eye Institute".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Columbia University Medical Center, Edward Harkness Eye Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Columbia University Medical Center, Edward Harkness Eye Institute, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".